APPLIED DNA SCIENCES INC's ticker is APDN and the CUSIP is 03815U201. A total of 36 filers reported holding APPLIED DNA SCIENCES INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $24,000 | -93.1% | 60,835 | -78.1% | 0.01% | -90.7% |
| Q2 2018 | $349,000 | -73.3% | 277,319 | -69.5% | 0.05% | -30.8% |
| Q1 2018 | $1,308,000 | -11.7% | 908,762 | -2.5% | 0.08% | -42.2% |
| Q4 2017 | $1,482,000 | -14.7% | 932,350 | -5.6% | 0.14% | +18.4% |
| Q2 2017 | $1,738,000 | -40.7% | 987,593 | -44.3% | 0.11% | -27.8% |
| Q1 2017 | $2,930,000 | -24.9% | 1,771,839 | -16.0% | 0.16% | -30.4% |
| Q4 2016 | $3,903,000 | +1250.5% | 2,109,601 | +2159.4% | 0.23% | +1963.6% |
| Q2 2015 | $289,000 | -77.5% | 93,368 | -81.2% | 0.01% | -79.2% |
| Q1 2015 | $1,284,000 | – | 495,700 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Benchmark Capital Advisors | 180,000 | $549,000 | 0.41% |
| CHASE INVESTMENT COUNSEL CORP | 77,563 | $236,000 | 0.10% |
| Crosspoint Capital Strategies, LLC | 19,321 | $59,000 | 0.08% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 20,921 | $64,000 | 0.03% |
| REILLY FINANCIAL ADVISORS, LLC | 50,000 | $153,000 | 0.03% |
| Onex Canada Asset Management Inc. | 20,000 | $60,000 | 0.01% |
| WILLIAMS JONES & ASSOCIATES LLC | 48,050 | $147,000 | 0.00% |
| D. SCOTT NEAL, INC. | 384 | $1,000 | 0.00% |
| OPPENHEIMER & CO INC | 13,527 | $41,000 | 0.00% |
| Creative Planning | 56,234 | $172,000 | 0.00% |